Mammalian Target of Rapamycin as a Rational Therapeutic Target for Breast Cancer Treatment

Publisher： Karger

E-ISSN： 1423-0232|84|1|43-56

ISSN： 0030-2414

Source： Oncology, Vol.84, Iss.1, 2012-10, pp. : 43-56

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer

By  

CANCER, Vol. 120, Iss. 4, 2014-02 ,pp. : 603-610

John Wiley & Sons Inc

Access to resources Recommend Favorite

Limited Significance of Activated Akt-Mammalian Target of Rapamycin Signaling Pathway in Prostate Cancer Progression

By  

Urologia Internationalis, Vol. 93, Iss. 2, 2014-02 ,pp. : 146-151

Karger

Access to resources Recommend Favorite

Mammalian target of rapamycin inhibition after solid organ transplantation: can it, and does it, reduce cancer risk?

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 7, 2015-07 ,pp. : 654-663

John Wiley & Sons Inc

Access to resources Recommend Favorite

VEGF as a Therapeutic Target in Cancer

By  

Oncology, Vol. 69, Iss. 3, 2005-11 ,pp. : 11-16

Karger

Access to resources Recommend Favorite

Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia

By  

ANNALS OF NEUROLOGY, Vol. 77, Iss. 4, 2015-04 ,pp. : 720-725

John Wiley & Sons Inc

Access to resources Recommend Favorite